SCHEMBL2991810

SCHEMBL2991810

COC(=O)c1ccc(Oc2ccc(CC(=O)OC(C)(C)C)cc2C(N)S(C)(=O)=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.38
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
STS P08842 1/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
HTT P42858 1/20 0.36
LOXL2 Q9Y4K0 1/20 0.36
USP2 O75604 1/20 0.35
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
LPAR1 Q92633 1/20 0.34
LPAR5 Q9H1C0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2975708 0.83 MEN1 (0.41) KMT2AALDH1A1HPGDMAPTLMNA
SCHEMBL2979962 0.80 LOXL2 (0.46) KMT2AMTNR1AMTNR1BALDH1A1HPGD
SCHEMBL2991813 0.80 SLC6A4 (0.48) KMT2AMTNR1AMTNR1BALDH1A1HPGD
SCHEMBL5128416 0.79 SLC6A4 (0.43) KMT2AMTNR1AMTNR1BALDH1A1HPGD
SCHEMBL5128413 0.77 MTNR1A (0.39) KMT2AMTNR1AMTNR1BALDH1A1HPGD
SCHEMBL2984362 0.77 MAPK14 (0.40) KMT2AMTNR1AMTNR1BALDH1A1HPGD
SCHEMBL2650122 0.73 LOXL2 (0.54) KMT2AMTNR1AMTNR1BMAPTLMNA
SCHEMBL2987824 0.73 PPARD (0.46) KMT2ALOXL2
SCHEMBL2985003 0.72 ALDH1A1 (0.40) MTNR1AMTNR1BALDH1A1HPGDMAPT
SCHEMBL2984377 0.72 NR1H4 (0.45) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 US disclosed
EP-2057115-B9 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-12-26 EP disclosed
EP-2057115-B1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-10-03 EP disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 US disclosed
US-8183289-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2012-05-22 US disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 US disclosed
EP-2057115-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2009-05-13 EP disclosed
WO-2008024746-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA, INC. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 KMT2A 505/4885MTNR1A 364/4885MTNR1B 339/4885
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 KMT2A 505/4885MTNR1A 364/4885MTNR1B 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.